Anixa begins treatment of fourth patient in phase 1 ovarian cancer tiral By Investing.com
© Reuters.
SAN JOSE, Calif. – Anixa Biosciences, Inc. (NASDAQ: NASDAQ:), a biotech company specializing in cancer treatment, has started treating the fourth patient in its phase 1 clinical trial for a novel ovarian cancer therapy.…
